TUNG ROGER D (Chief Executive Officer) sold 0.9% of their position (9.24K shares) of CONCERT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $66.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/9/2023ACC: 0001209191-23-002556
DirectorOfficer· Chief Executive Officer
Since Jan 2019
-9.24K
Net shares
Net seller
$66.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.24K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.24K
Price / share
$7.24
Trade value
$66.90K
% of position
0.9%
1/6/2023
980.26K→971.02K
Total
Net shares
−9.24K
Net value
-$66.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2023 | S · Sale | −9.24K | $7.24 | $66.90K | 0.9% | 980.26K | 971.02K |
| Total | −9.24K | -$66.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned13.27K
Common Stock
IndirectShares owned121.87K
Common Stock
IndirectShares owned12.39K
Total
147.54K indirect147.54K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.27K | Indirect |
| Common Stock | 121.87K | Indirect |
| Common Stock | 12.39K | Indirect |
| Total | 147.54K | 147.54K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported